The Asston Pharmaceuticals IPO GMP has become a hot topic among SME investors as the company prepares to launch its IPO in 2025. Asston Pharmaceuticals, engaged in manufacturing pharmaceutical formulations, is known for its strong R&D and export presence. According to data available on Finowings, the current Grey Market Premium (GMP) for Asston Pharmaceuticals IPO is trending between ₹18–₹22, reflecting healthy demand in the pre-listing phase. The IPO aims to raise funds for working capital, R&D expansion, and other corporate purposes. Here’s the complete IPO timeline to help investors plan their bids strategically:
Asston Pharmaceuticals IPO Timeline:
-
IPO Open Date: July 9, 2025
-
IPO Close Date: July 11, 2025
-
Basis of Allotment: July 14, 2025
-
Refund Initiation: July 15, 2025
-
Shares Credited to Demat: July 15, 2025
-
IPO Listing Date: July 16, 2025
Investors are recommended to monitor the Asston Pharmaceuticals IPO GMP daily through Finowings to track market sentiment and listing expectations. With a solid foundation in pharma manufacturing, this IPO could offer strong returns depending on the final subscription numbers and GMP trends.
Comments
0 comment